1) Nozu K, et al : A review of clinical characteristics and genetic backgrounds in Alport syndrome. Clin Exp Nephrol 23 : 158-168, 2019.
2) Kashtan CE, et al : Alport syndrome : a unified classification of genetic disorders of collagen IV α345 : a position paper of the Alport Syndrome Classification Working Group. Kidney Int 93 : 1045-1051, 2018.
3) アルポート症候群診療ガイドライン 2017 (日本小児腎臓病学会編), 診断と治療社, 2017.
4) Nakanishi K, et al : Immunohistochemical study of α1-5 chains of type IV collagen in hereditary nephritis. Kidney Int 46 : 1413-1421, 1994.
5) Hashimura Y, et al : Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV α5 chain. Kidney Int 85 : 1208-1213, 2014.
6) Yamamura T, et al : Genotype-phenotype correlations influence the response to angiotensin-targeting drugs in Japanese patients with male X-linked Alport syndrome. Kidney Int 98 : 1605-1614, 2020.
7) Yamamura T, et al : Natural History and Genotype-Phenotype Correlation in Female X-Linked Alport Syndrome. Kidney Int Rep 2 : 850-855, 2017.
8) Oka M, et al : Natural history of genetically proven autosomal recessive Alport syndrome. Pediatr Nephrol 29 : 1535-1544, 2014.
9) Kamiyoshi N, et al : Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome. Clin J Am Soc Nephrol 11 : 1441-1449, 2016.